Showing results (1341-1350 of 1,376) with videos related to
Sort By:
Pageof 138
Neuro-Oncology Advances|August 29, 2022
Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomasNicholas S Cho, Akifumi Hagiwara, Blaine S C Eldred, et al.Neuro-Oncology Advances|June 24, 2026
Cancer treatment-related cognitive impairmentBryan J Neth, Sanne B Schagen, Jeffrey S WefelNeuro-Oncology Advances|June 4, 2026
Spherical radiomics for radiogenomic assessment of glioblastoma heterogeneityHaotian Feng, Ke ShengNeuro-Oncology Advances|May 29, 2026
Inhibition of chemokine CXCL12 modulates the tumor microenvironment in glioblastoma and potentiates immune checkpoint inhibitor efficacy in a tissue-specific mannerChen Makranz, Caitlin Huguely, Meili Zhang, et al.Neuro-Oncology Advances|May 29, 2026
Systematic decoding the functional role of human endogenous retrovirus-derived RNAs in medulloblastomaJiaming Zhao, Wei Yang, Tingting Wang, et al.Neuro-Oncology Advances|June 1, 2026
OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastomaAunay Miller, James McNamara, Mylan R Blomquist, et al.Neuro-Oncology Advances|June 1, 2026
Neurosurgical oncology at the crossroads of neurosurgery subspecialties: Intersections of sectionsIsabelle M Germano, Gelareh ZadehNeuro-Oncology Advances|June 1, 2026
Surgical techniques for patients with cancer-related neuropathic painErica Gillespie, Elise Bouchal, Gordon Li, et al.Neuro-Oncology Advances|May 18, 2026
Real-world mortality and the effect of comorbidities on survival in glioblastoma: A database study using computed phenotypes for rapid, reliable patient identificationRuoqi Wei, Megan E H Still, Rachel S F Moor, et al.Neuro-Oncology Advances|May 18, 2026
Cerebrospinal fluid soluble protein tyrosine phosphatase receptor type Z detected with human natural killer-1 antibody as a practical biomarker for glioma diagnosisYu Naruse, Masazumi Fujii, Kenichiro Nagai, et al.Pageof 138